Showing results (221-230 of 295) with videos related to
Sort By:
Pageof 30
Molecular Pathology : MP|July 31, 2002
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell linesJ Mad'arová, M Lukesová, A Hlobilková, et al.Diagnostics (Basel, Switzerland)|February 26, 2025
Trends in Clinical Cardiac Photon-Counting Detector CT Research: A Comprehensive Bibliometric AnalysisArosh S Perera Molligoda Arachchige, Federica Catapano, Costanza Lisi, et al.Biosensors & Bioelectronics|February 20, 2025
Rapid and selective detection of TP53 mutations in cancer using a novel conductometric biosensorGanganath S Perera, Xiaomin Huang, Fateme Akhlaghi Bagherjeri, et al.BMC Research Notes|June 3, 2014
Cryptococcal meningitis presenting with bilateral complete ophthalmoplegia: a case reportDamith S Liyanage, Lakmini P S Pathberiya, Inuka K Gooneratne, et al.ACS Applied Bio Materials|October 22, 2025
Conductometric Biosensor for Quick Detection of Urinary Biomarkers in Chronic Kidney Disease ManagementSreekanth S P, Ganganath S Perera, Shanmuga Sundar Dhanabalan, et al.Internal Medicine Journal|November 19, 2014
Enteric fever in the Pacific: a regional retrospective study from Auckland, New ZealandR J Lane, D Holland, S McBride, et al.Pharmacognosy Research|December 11, 2012
In vitro erythrocyte membrane stabilization properties of Carica papaya L. leaf extractsPriyanga Ranasinghe, Pathmasiri Ranasinghe, W P Kaushalya M Abeysekera, et al.Asia Pacific Family Medicine|November 26, 2011
Can we bridge the gap? Knowledge and practices related to Diabetes Mellitus among general practitioners in a developing country: A cross sectional studyPrasad Katulanda, Godwin R Constantine, Muditha I Weerakkody, et al.Clinical Trials (London, England)|December 14, 2011
Lessons learned from an osteoporosis clinical trial in frail long-term care residentsSl Greenspan, D Nace, S Perera, et al.Journal of Pharmaceutical and Biomedical Analysis|January 11, 2024
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasmaBarend J Sikkema, Ron H J Mathijssen, Debbie G J Robbrecht, et al.Pageof 30